Ted Love
Cardiovascular Disease · Hillsborough, CANPI 1417299728
Payments from drug & device makers
What this record shows
This record is dominated by other: $101,367,454 of the $102,778,624 with a category attached, or 98.6%. Pfizer accounts for 98.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $98,897,158 and has fallen 99.4% since, to $581,800 in 2025. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $590,682 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$101.4M
- Gilead$858K
- Tarsus Pharmaceuticals, Inc.$405K
- Amicus Therapeutics, Inc.$139K
- Jazz Pharmaceuticals Inc.$9K
- Ultragenyx Pharmaceutical Inc.$65
What the payments were for
- Consulting fees$1,142,6871%
- Speaking & faculty fees$209,2530%
- Travel & lodging$51,9000%
- Food & beverage$6,0480%
- Gifts$1,2820%
- Other$101,367,45499%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 22 | $101,367,454 |
| Gilead | 72 | $858,230 |
| Tarsus Pharmaceuticals, Inc. | 47 | $404,771 |
| Amicus Therapeutics, Inc. | 16 | $139,060 |
| Jazz Pharmaceuticals Inc. | 16 | $9,044 |
| Ultragenyx Pharmaceutical Inc. | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$238
How this compares
$102,778,624 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Hillsborough
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
- Thomas SmithSacramento$942K
- Nassir Azimila Mesa$779K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.